NEW YORK (360Dx) — French diagnostics firm Novacyt said today that it has entered a convertible bond facility for up to €5.0 million ($5.6 million) with Park Partners and Negma Group.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.